"Chemokine CCL4" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A CC chemokine with specificity for CCR5 RECEPTORS. It is a chemoattractant for NK CELLS; MONOCYTES and a variety of other immune cells. This chemokine is encoded by multiple genes.
| Descriptor ID |
D054407
|
| MeSH Number(s) |
D12.644.276.374.200.110.200 D12.644.276.374.200.600.200 D12.776.467.374.200.110.200 D12.776.467.374.200.600.200 D23.125.300.110.200 D23.125.300.600.750 D23.469.200.110.200 D23.529.374.200.110.200 D23.529.374.200.600.200
|
| Concept/Terms |
Chemokine CCL4- Chemokine CCL4
- CCL4, Chemokine
- Macrophage Inflammatory Protein 1-beta
- Macrophage Inflammatory Protein 1 beta
- MIP-1beta
- MIP 1beta
- CCL4 Chemokine
- Chemokine, CCL4
Chemokine CCL4L1- Chemokine CCL4L1
- CCL4L1, Chemokine
- Macrophage Inflammatory Protein-1beta2
- Inflammatory Protein-1beta2, Macrophage
- Macrophage Inflammatory Protein 1beta2
- CCL4L1 Chemokine
- Chemokine, CCL4L1
Chemokine CCL4L2- Chemokine CCL4L2
- CCL4L2, Chemokine
- CCL4L2 Chemokine
- Chemokine, CCL4L2
|
Below are MeSH descriptors whose meaning is more general than "Chemokine CCL4".
Below are MeSH descriptors whose meaning is more specific than "Chemokine CCL4".
This graph shows the total number of publications written about "Chemokine CCL4" by people in this website by year, and whether "Chemokine CCL4" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 |
| 1998 | 0 | 1 | 1 |
| 2000 | 0 | 2 | 2 |
| 2001 | 0 | 2 | 2 |
| 2002 | 0 | 3 | 3 |
| 2004 | 0 | 6 | 6 |
| 2005 | 0 | 1 | 1 |
| 2008 | 1 | 0 | 1 |
| 2009 | 1 | 1 | 2 |
| 2010 | 0 | 1 | 1 |
| 2012 | 0 | 1 | 1 |
| 2013 | 0 | 2 | 2 |
| 2014 | 0 | 2 | 2 |
| 2015 | 1 | 1 | 2 |
| 2016 | 1 | 2 | 3 |
| 2017 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Chemokine CCL4" by people in Profiles.
-
Pharmacodynamics and proteomic analysis of acalabrutinib therapy: similarity of on-target effects to ibrutinib and rationale for combination therapy. Leukemia. 2018 04; 32(4):920-930.
-
Dynamic changes in CCL3 and CCL4 plasma concentrations in patients with chronic lymphocytic leukaemia managed with observation. Br J Haematol. 2018 02; 180(4):597-600.
-
Increased Proinflammatory Responses of Monocytes and Plasmacytoid Dendritic Cells to Influenza A Virus Infection During Pregnancy. J Infect Dis. 2016 Dec 01; 214(11):1666-1671.
-
Functional Differences between IgM and IgD Signaling in Chronic Lymphocytic Leukemia. J Immunol. 2016 09 15; 197(6):2522-31.
-
CCL3 and CCL4 are biomarkers for B cell receptor pathway activation and prognostic serum markers in diffuse large B cell lymphoma. Br J Haematol. 2015 Dec; 171(5):726-35.
-
The phosphoinositide-3-kinase (PI3K)-delta and gamma inhibitor, IPI-145 (Duvelisib), overcomes signals from the PI3K/AKT/S6 pathway and promotes apoptosis in CLL. Leukemia. 2015 Sep; 29(9):1811-22.
-
Enhanced natural killer-cell and T-cell responses to influenza A virus during pregnancy. Proc Natl Acad Sci U S A. 2014 Oct 07; 111(40):14506-11.
-
The bruton tyrosine kinase inhibitor ibrutinib (PCI-32765) blocks hairy cell leukaemia survival, proliferation and B cell receptor signalling: a new therapeutic approach. Br J Haematol. 2014 Jul; 166(2):177-88.
-
Beyond the IFN-? horizon: biomarkers for immunodiagnosis of infection with Mycobacterium tuberculosis. Eur Respir J. 2014 May; 43(5):1472-86.
-
Multiplex cytokine concentration measurement: how much do the medium and handling matter? Mediators Inflamm. 2013; 2013:890706.